DEA schedule
Is lorazepam a controlled substance?
Federal schedule for lorazepam from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Lorazepam is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lorazepam (Schedule IV).
Run it in Rivvi
Which 2027 plans near you dropped or restricted lorazepam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 148 prescription listings from 39 labelers, all Schedule IV |
| DEA controlled substances list | Lorazepam: Schedule IV |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Lorazepam | 2885 | IV | No | Ativan | Listed by name |
Lorazepam NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0641-6000 | Ativan | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6001 | Ativan | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6002 | Ativan | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6003 | Ativan | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0187-0063 | Ativan | tablet | .5 mg/1 | Bausch Health US LLC | CIV |
| 0187-0064 | Ativan | tablet | 1 mg/1 | Bausch Health US LLC | CIV |
| 0187-0065 | Ativan | tablet | 2 mg/1 | Bausch Health US LLC | CIV |
| 0641-6044 | Lorazepam | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6046 | Lorazepam | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6048 | Lorazepam | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6050 | Lorazepam | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6207 | Lorazepam | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 72572-380 | Lorazepam | injection | 2 mg/mL | Civica, Inc. | CIV |
| 0641-6045 | Lorazepam | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6047 | Lorazepam | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6049 | Lorazepam | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6051 | Lorazepam | injection | 4 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 52427-658 | LOREEV XR | capsule, extended release | 1 mg/1 | Almatica Pharma LLC | CIV |
| 50090-7592 | LOREEV XR | capsule, extended release | 1.5 mg/1 | A-S Medication Solutions | CIV |
| 52427-661 | LOREEV XR | capsule, extended release | 1.5 mg/1 | Almatica Pharma LLC | CIV |
| 52427-663 | LOREEV XR | capsule, extended release | 2 mg/1 | Almatica Pharma LLC | CIV |
| 52427-667 | LOREEV XR | capsule, extended release | 3 mg/1 | Almatica Pharma LLC | CIV |
| 62135-549 | Lorazepam | concentrate | 2 mg/mL | Chartwell RX, LLC | CIV |
| 65162-687 | Lorazepam | concentrate | 2 mg/mL | Amneal Pharmaceuticals LLC | CIV |
| 65219-368 | Lorazepam | injection | 2 mg/mL | Fresenius Kabi USA, LLC | CIV |
| 65219-368 | Lorazepam | injection | 2 mg/mL | Fresenius Kabi USA, LLC | CIV |
| 76329-8261 | Lorazepam | injection | 2 mg/mL | International Medication Systems, Limited | CIV |
| 0409-1985 | Lorazepam | injection, solution | 2 mg/mL | Hospira, Inc. | CIV |
| 70518-3766 | Lorazepam | injection, solution | 2 mg/mL | REMEDYREPACK INC. | CIV |
| 0121-0770 | Lorazepam | liquid | 2 mg/mL | Pharmaceutical Associates, Inc. | CIV |
| 68000-107 | Lorazepam | liquid | 2 mg/mL | American Health Packaging | CIV |
| 68000-108 | Lorazepam | liquid | 2 mg/mL | American Health Packaging | CIV |
| 0054-3532 | Lorazepam | solution, concentrate | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0093-3425 | Lorazepam | tablet | .5 mg/1 | Teva Pharmaceuticals USA, Inc. | CIV |
| 13107-083 | LORAZEPAM | tablet | .5 mg/1 | Aurolife Pharma LLC | CIV |
| 51407-996 | Lorazepam | tablet | .5 mg/1 | Golden State Medical Supply, Inc. | CIV |
| 58118-0904 | Lorazepam | tablet | .5 mg/1 | Clinical Solutions Wholesale, LLC | CIV |
| 60687-820 | Lorazepam | tablet | .5 mg/1 | American Health Packaging | CIV |
| 60760-947 | Lorazepam | tablet | .5 mg/1 | St. Mary's Medical Park Pharmacy | CIV |
| 61919-062 | LORAZEPAM | tablet | .5 mg/1 | DIRECT RX | CIV |
Showing 40 of 148 listings.
Questions
Is lorazepam a controlled substance?
Yes. Lorazepam is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lorazepam (Schedule IV).
Is lorazepam a narcotic?
No. The DEA list does not mark lorazepam as a narcotic (NARC = N) and places it in Schedule IV. Its FDA established pharmacologic class is Benzodiazepine.
What schedule is lorazepam?
Lorazepam is Schedule IV in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Lorazepam
- What is Lorazepam used for?FDA label uses
- Generic for Loreev XRFDA Orange Book
- Generic for AtivanFDA Orange Book
- What is Ativan used for?FDA label uses
- Is Ativan a controlled substance?Schedule IV
- What is Loreev XR used for?FDA label uses
- Is Loreev XR a controlled substance?Schedule IV
- Benzodiazepines listFDA drug class
- NDC 0187-0063Lorazepam NDC record
- NDC 0187-0064Lorazepam NDC record
- NDC 0187-0065Lorazepam NDC record
- Schedule IV drugs listDEA schedule